In a bold stride towards next-generation protection against COVID-19, Moderna has officially announced FDA approval of its newest vaccine, mNexspike. Unlike earlier vaccines that followed a one-size-fits-all framework, mNexspike represents a carefully engineered evolution—delivering protection with a significantly lower dosage. This refined design is especially attuned to the needs of older adults and those living […]